CN113197943A - Rehabilitation wine for myocardial infarction and preparation method thereof - Google Patents

Rehabilitation wine for myocardial infarction and preparation method thereof Download PDF

Info

Publication number
CN113197943A
CN113197943A CN202110299290.4A CN202110299290A CN113197943A CN 113197943 A CN113197943 A CN 113197943A CN 202110299290 A CN202110299290 A CN 202110299290A CN 113197943 A CN113197943 A CN 113197943A
Authority
CN
China
Prior art keywords
parts
wine
rehabilitation
myocardial infarction
hawthorn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110299290.4A
Other languages
Chinese (zh)
Inventor
曾山平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202110299290.4A priority Critical patent/CN113197943A/en
Publication of CN113197943A publication Critical patent/CN113197943A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537Salvia (sage)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/486Millettia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/734Crataegus (hawthorn)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention relates to the technical field of rehabilitation wine and discloses rehabilitation wine for myocardial infarction and a preparation method thereof, wherein the rehabilitation wine comprises the following components in parts by weight: 15-25 parts of salvia miltiorrhiza, 10-20 parts of hawthorn, 10-20 parts of pseudo-ginseng and 550 parts of suberect spatholobus stem. The invention provides a rehabilitation wine for myocardial infarction and a preparation method thereof.

Description

Rehabilitation wine for myocardial infarction and preparation method thereof
Technical Field
The invention relates to the field of rehabilitation wine, in particular to rehabilitation wine for myocardial infarction and a preparation method thereof.
Background
Acute myocardial infarction is myocardial necrosis caused by acute and persistent ischemia and hypoxia of coronary artery. Clinically, severe and persistent poststernal pain, rest and incomplete relief of nitrate medicines are caused, and the increased activity of serum myocardial enzyme and progressive electrocardiogram change are accompanied, so that arrhythmia, shock or heart failure can occur, and the life can be threatened. The disease is most common in europe and the united states, and about 150 million people suffer myocardial infarction in the united states each year. China has a remarkable rising trend in recent years, newly issues at least 50 ten thousand every year, and finds out at least 200 ten thousand.
However, the effect of the existing medicines for treating myocardial infarction needs to be improved, and some problems still exist, so that the rehabilitation wine for myocardial infarction and the preparation method thereof are provided.
Disclosure of Invention
Objects of the invention
The invention provides rehabilitation wine for myocardial infarction and a preparation method thereof, and aims to solve the technical problems in the background art.
(II) technical scheme
In order to solve the problems, the invention provides rehabilitation wine for myocardial infarction, which comprises the following components in parts by weight:
15-25 parts of salvia miltiorrhiza, 10-20 parts of hawthorn, 10-20 parts of pseudo-ginseng and 550 parts of suberect spatholobus stem.
Preferably, the composition consists of the following components in parts by weight:
15-20 parts of salvia miltiorrhiza, 10-25 parts of hawthorn, 10-15 parts of pseudo-ginseng and 500 parts of suberect spatholobus stem 450-.
Preferably, the composition consists of the following components in parts by weight:
20-25 parts of salvia miltiorrhiza, 15-20 parts of hawthorn, 15-20 parts of pseudo-ginseng and 500-550 parts of suberect spatholobus stem.
A rehabilitation wine for myocardial infarction is prepared by the following steps:
s1, selecting raw materials, and cleaning the raw materials for use;
s2, filling 4-6 jin of wine into a tile can;
s3, mixing radix Salviae Miltiorrhizae, fructus crataegi and radix Notoginseng, adding into a jar, and mixing;
s4, soaking the infant for 6-8 days, and then the infant can drink the infant.
Preferably, in S2, the wine is filled into the crock with 20 degree rice wine.
The technical scheme of the invention has the following beneficial technical effects:
the myocardial infarction specific wine is beneficial to conditioning and convenient to prepare.
Drawings
Fig. 1 is a structural schematic diagram of rehabilitation wine for myocardial infarction and a preparation method thereof.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, the present invention will be described in further detail with reference to the accompanying drawings 1 in conjunction with the following detailed description. It should be understood that the description is intended to be exemplary only, and is not intended to limit the scope of the present invention. Moreover, in the following description, descriptions of well-known structures and techniques are omitted so as to not unnecessarily obscure the concepts of the present invention.
Example 1
A rehabilitation wine for myocardial infarction comprises the following components in parts by weight:
20 parts of salvia miltiorrhiza, 15 parts of hawthorn, 15 parts of pseudo-ginseng and 500 parts of suberect spatholobus stem.
A rehabilitation wine for myocardial infarction is prepared by the following steps:
s1, selecting raw materials, and cleaning the raw materials for use;
s2, selecting 5 jin of wine and filling the wine into a tile can;
s3, mixing radix Salviae Miltiorrhizae, fructus crataegi and radix Notoginseng, adding into a jar, and mixing;
s4, soaking the tea for 7 days, and then the tea can be drunk.
Preferably, in S2, the wine is filled into the crock with 20 degree rice wine.
Example 2
A rehabilitation wine for myocardial infarction comprises the following components in parts by weight:
18 parts of salvia miltiorrhiza, 17 parts of hawthorn, 13 parts of pseudo-ginseng and 475 parts of suberect spatholobus stem.
A rehabilitation wine for myocardial infarction is prepared by the following steps:
s1, selecting raw materials, and cleaning the raw materials for use;
s2, selecting 4 jin of wine and filling the wine into a tile can;
s3, mixing radix Salviae Miltiorrhizae, fructus crataegi and radix Notoginseng, adding into a jar, and mixing;
s4, soaking the tea for 6 days, and then the tea can be drunk.
Preferably, in S2, the wine is prepared by filling 20% (v/v) rice wine into earthen jar
Example 3
A rehabilitation wine for myocardial infarction comprises the following components in parts by weight:
25 parts of salvia miltiorrhiza, 20 parts of hawthorn, 20 parts of pseudo-ginseng and 550 parts of suberect spatholobus stem.
A rehabilitation wine for myocardial infarction is prepared by the following steps:
s1, selecting raw materials, and cleaning the raw materials for use;
s2, selecting 6 jin of wine, and filling the wine into a tile can;
s3, mixing radix Salviae Miltiorrhizae, fructus crataegi and radix Notoginseng, adding into a jar, and mixing;
s4, soaking the tea for 8 days, and then the tea can be drunk.
In an alternative embodiment, at S2, the wine is filled into a crock with 20 degree rice wine.
The finished products of example 1, example 2 and example 3 were taken three times a day with 2 to 5 caps each time, and five to two money of wine could be consumed, and bitter gourd could not be consumed after meal.
Example 4
The following three patients were treated with this medicated wine: certain Liu, a male coronary artery of 56 years old is blocked, blood supply is insufficient, and the treatment is repeated repeatedly and ineffective for a long time; a certain king, male 61 years old, feels dysphoria, palpitation, urgency, precordial pain, and general weakness while active; old certain people, 60 years old, may have nausea, profuse sweating, tachycardia or be accompanied by cardiac insufficiency. The three patients who go to the hospital have no good effect, and the medicated wine is given to the patients to treat the diseases, so that the diseases are corrected, and the diseases do not occur after the patients persist.
It is to be understood that the above-described embodiments of the present invention are merely illustrative of or explaining the principles of the invention and are not to be construed as limiting the invention. Therefore, any modification, equivalent replacement, improvement and the like made without departing from the spirit and scope of the present invention should be included in the protection scope of the present invention. Further, it is intended that the appended claims cover all such variations and modifications as fall within the scope and boundaries of the appended claims or the equivalents of such scope and boundaries.

Claims (5)

1. The rehabilitation wine for myocardial infarction is characterized by comprising the following components in parts by weight:
15-25 parts of salvia miltiorrhiza, 10-20 parts of hawthorn, 10-20 parts of pseudo-ginseng and 550 parts of suberect spatholobus stem.
2. The rehabilitation wine for myocardial infarction as claimed in claim 1, which is characterized by comprising the following components in parts by weight:
15-20 parts of salvia miltiorrhiza, 10-25 parts of hawthorn, 10-15 parts of pseudo-ginseng and 500 parts of suberect spatholobus stem 450-.
3. The rehabilitation wine for myocardial infarction as claimed in claim 1, which is characterized by comprising the following components in parts by weight:
20-25 parts of salvia miltiorrhiza, 15-20 parts of hawthorn, 15-20 parts of pseudo-ginseng and 500-550 parts of suberect spatholobus stem.
4. A rehabilitation liquor for myocardial infarction according to any one of claims 1 to 3, characterized in that it is prepared by the following steps:
s1, selecting raw materials, and cleaning the raw materials for use;
s2, filling 4-6 jin of wine into a tile can;
s3, mixing radix Salviae Miltiorrhizae, fructus crataegi and radix Notoginseng, adding into a jar, and mixing;
s4, soaking the infant for 6-8 days, and then the infant can drink the infant.
5. The method of claim 4, wherein the wine is prepared by filling 20% (v/v) rice wine into a crock at S2.
CN202110299290.4A 2021-03-21 2021-03-21 Rehabilitation wine for myocardial infarction and preparation method thereof Pending CN113197943A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110299290.4A CN113197943A (en) 2021-03-21 2021-03-21 Rehabilitation wine for myocardial infarction and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110299290.4A CN113197943A (en) 2021-03-21 2021-03-21 Rehabilitation wine for myocardial infarction and preparation method thereof

Publications (1)

Publication Number Publication Date
CN113197943A true CN113197943A (en) 2021-08-03

Family

ID=77025513

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110299290.4A Pending CN113197943A (en) 2021-03-21 2021-03-21 Rehabilitation wine for myocardial infarction and preparation method thereof

Country Status (1)

Country Link
CN (1) CN113197943A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105213574A (en) * 2015-11-09 2016-01-06 广东聚智诚科技有限公司 A kind of Chinese medicine composition for the treatment of myocardial infarction and preparation method thereof
CN109453248A (en) * 2017-09-06 2019-03-12 熊月旺 A kind of Chinese medicine preparation for treating cardiovascular and cerebrovascular disease

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105213574A (en) * 2015-11-09 2016-01-06 广东聚智诚科技有限公司 A kind of Chinese medicine composition for the treatment of myocardial infarction and preparation method thereof
CN109453248A (en) * 2017-09-06 2019-03-12 熊月旺 A kind of Chinese medicine preparation for treating cardiovascular and cerebrovascular disease

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
白刚等: "《中药方剂研究与应用大全》", 31 January 1995, 中国科学技术出版社 *

Similar Documents

Publication Publication Date Title
CN102669348B (en) Nutrition food of heart nourishing tea granule for nourishing heart
CN100518776C (en) Health protection tea for reducing blood pressure, and blood fat, and preparation method
CN103103074A (en) Healthful wine
CN113197943A (en) Rehabilitation wine for myocardial infarction and preparation method thereof
CN1308879A (en) Health-care tea and its preparing process
CN102920807A (en) Herb tea for lowering blood pressure
CN100515486C (en) Medicine for treating senile dementia and its preparing process
CN102326813A (en) Salvia miltiorrhiza bge.f.alba functional beverage and preparation method thereof
CN108355055A (en) A kind of pharmaceutical composition for treating hypertension
CN103212016A (en) Active biological enzyme extracting solution for treating diabetes wounds
CN103798472B (en) A kind of health protection tea and health care's preparation
CN110170003A (en) A kind of life heart tea and preparation method thereof for the treatment of of vascular hardening
CN1126469C (en) Health manyprickle acanthopanax beverage and its making process
CN1125646C (en) Solid beverage for prevention and control of essential hypertension and productive method thereof
CN108014267A (en) A kind of liter is immunized, reducing blood lipid, the Chinese medicine composition and preparation method thereof for protecting heart and brain
CN1374121A (en) Baggod health gingko tea and its prepn
CN102755444A (en) Traditional Chinese medicine composition for treating hyperlipidemia and preparation method thereof
CN107349352A (en) A kind of decoction of medicinal ingredients for improving sleep quality and preparation method thereof
CN107320652A (en) A kind of medicine spray for treating tinea pedis
CN1056981C (en) "Tongmailing" -medicine for promoting blood-circulation and production technology thereof
CN101953941B (en) Chinese medicinal liquor for treating femoral head necrosis
CN106138714B (en) A kind of Chinese materia medica preparation for treating heart failure with preserved ejection fraction
CN101306101A (en) Medicine for treating thrombus and its preparation method
CN103800406A (en) Compound organic zinc preparation
CN112915185A (en) Pharmaceutical composition and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20210803

RJ01 Rejection of invention patent application after publication